Approximately 5,000 square feet of the current Technology Center will be converted to newly reconstructed laboratory space for dissolution testing (Apparatus I, II, III, IV and intrinsic dissolution), Karl Fischer testing (humidity controlled room), microbiology, and formulations development.
According to the Alcami (the newly rebranded company combining AAI Pharma Services and Cambridge Major Labs), the new space adds 15% additional capacity for dissolution in addition to a new UV sampling automation capability.
The announcement is the latest in a series of equipment and personnel investments – since January 2015, Alcami has grown its development teams by 10% and has invested $1.6m in equipment.
New construction, which was announced in November 2015, will bring additional laboratory capacity. One of the additional five lab spaces has been completed with the remaining labs expected to be finished by the end of the year.
Additionally, as Outsourcing-Pharma.com reported in March, Alcami previously announced an $11m investment in its Cortex innovation center in St. Louis, Missouri.